Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
60.0%
% of FBT's 31 holdings also in WDNA
21.4%
% of WDNA's 90 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.3% | 3.7% | 3.3% |
|
VERACYTE INC | 3.3% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 3.4% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 3.4% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 3.4% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to WDNA
|
NEUROCRINE BIOSCIENCES INC | 3.7% |
|
EXELIXIS INC | 3.4% |
|
INCYTE CORP | 3.4% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
ACADIA PHARMACEUTICALS INC | 3.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.3% |
 |
ALKERMES PLC | 3.3% |
|
WATERS CORP | 3.3% |
|
HALOZYME THERAPEUTICS INC | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.2% |
FBT Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
NOVARTIS AG | -1.7% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
LABCORP HOLDINGS | -1.5% |